01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

#VELA investee co. #SKL Skillcast Group PLC – Interim Results September 27, 2023 – Posted in: Vela Technologies Plc (VELA)

Skillcast (AIM: SKL), the provider of SaaS compliance platforms and off-the-shelf e-learning courseware, is pleased to announce strong growth in recurring subscription revenue in its unaudited results for the six months ended 30 June 2023.  Highlights   6 months to 30 June 2023 (unaudited)  (H1 23)   6 months to 30 June 2022 (unaudited) (H1 22)   12 Months to 31 December 2022 (audited)   Change (H1 23 v H1 22) Revenue £5.2m £4.5m £9.8m…

Continue reading

#VELA Technologies PLC investee co #TRYB Tribe Tech PLC – Update on investment in Tribe Technology Group September 5, 2023 – Posted in: Uncategorized

The Board of Vela (AIM: VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, notes the admission to AIM and first day of dealings announcement made today by Tribe Technology PLC (“Tribe Tech”).   As announced on 23 May 2023, Vela invested £250,000 in Tribe Technology Group Limited, a subsidiary of Tribe Tech, via a subscription to an advance subscription agreement (“ASA”) as part of a pre-IPO funding round. Pursuant to…

Continue reading

#TSP TruSpine Technologies PLC – Subscription August 15, 2023 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems announces it has raised gross proceeds of £50,000 through the subscription of 2,000,000 new ordinary shares at a price of 2.5 pence per share (“Subscription Shares”) under its existing share authorities. Admission  Application has been made for the Subscription Shares to be admitted to trading on the Aquis Stock Exchange Growth Market on or…

Continue reading

#VELA Vela Technologies notes the Announcement Issued by Cizzle Biotech #CIZ in Relation to the Option Issued to Conduit re AZD1656 December 19, 2022 – Posted in: Blog, Vela Technologies Plc (VELA)

Cizzle Biotechnology Holdings plc (“Cizzle” or the “Company”) Put Option for Sale of Economic Interest and Royalty Sharing Agreement in AZD1656 Subscription to raise net proceeds of £115,586 at 1.6p per share Cizzle Biotechnology Holdings plc, the UK based diagnostics developer, is pleased to announce that it has agreed a put option to sell: (i) its 5% economic interest in the commercialisation of the AZD 1656 asset to treat inflammatory pulmonary and cardiovascular disease (the…

Continue reading